Drug Use Investigation of Fosrenol for Hyperphosphatemia With Chronic Kidney Disease Not on Dialysis
Phase of Trial: Phase IV
Latest Information Update: 26 Feb 2018
Price : $35 *
At a glance
- Drugs Lanthanum carbonate (Primary)
- Indications Hyperphosphataemia
- Focus Adverse reactions; Therapeutic Use
- Sponsors Bayer
- 31 Aug 2018 Biomarkers information updated
- 07 Dec 2016 Status changed from active, no longer recruiting to completed.
- 21 Jun 2016 Status changed from recruiting to active, no longer recruiting.